Characterizing the immune microenvironment updates and neoantigen landscape of Hürthle cell carcinoma to identify potential immunologic vulnerabilities Journal Article
| Authors: | Ganly, I.; Kuo, F.; Makarov, V.; Dong, Y.; Ghossein, R.; Xu, B.; Morris, L. G. T.; Chan, T. A. |
| Article Title: | Characterizing the immune microenvironment updates and neoantigen landscape of Hürthle cell carcinoma to identify potential immunologic vulnerabilities |
| Abstract: | Hurthle cell carcinoma (HCC) is a rare type of thyroid cancer with high rates of distant metastasis and recurrence. Along with the scarcity of effective systemic therapies for HCC, these factors contribute to poor clinical outcomes. The immunologic features of HCC are poorly defined and response rates with immune checkpoint blockade have not been reported. A more comprehensive understanding of the immune landscape and factors that predict response to checkpoint inhibitors is needed. We performed RNA sequencing on 40 tumors to characterize the neoantigen landscape and immune microenvironment of HCC. We analyzed transcriptomic profiles, tumor-infiltrating immune cell populations, and measures of T-cell activation/dysfunction and correlated these to genetic features such as tumor mutation burden, neoantigen burden, mitochondrial mutations, and LOH from chromosomal uniparental disomy. Finally, immune profiles of patients with recurrence were compared with those of patients without recurrence. HCC tumors exhibited low levels of immune infiltration, with the more aggressive widely invasive phenotype associated with more immune depletion. There was a negative correlation between tumor mutation burden, neoantigen burden, programmed cell death ligand 1 (PD-L1) expression, and the immune infiltration score. HCC tumors that exhibited a global LOH from chromosomal uniparental disomy or haploidization had the lowest level of immune infiltration. HCC tumors that recurred displayed an immune-depleted microenvironment associated with global LOH and aerobic glycolysis. These findings offer new insights into the functional immune landscapes and immune microenvironment of HCC. Our data identify potential immunologic vulnerabilities for these understudied and often fatal cancers. Significance: The immune landscape of HCC is poorly defined and response rates to immunotherapy have not been reported. The authors found the immune microenvironment in HCC to be depleted. This immunosuppression is associated with a global LOH from haploidization and uniparental disomy, resulting in whole chromosome losses across the genome. |
| Keywords: | chemotherapy; tumors; genome; safety; mutations; prognostic-factors; ctla-4 blockade; nivolumab; cancer; pd-1 blockade |
| Journal Title: | Cancer Research Communications |
| Volume: | 3 |
| Issue: | 7 |
| ISSN: | 2767-9764 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2023-07-01 |
| Start Page: | 1409 |
| End Page: | 1422 |
| Language: | English |
| ACCESSION: | WOS:001068012800013 |
| DOI: | 10.1158/2767-9764.Crc-23-0120 |
| PROVIDER: | wos |
| PMCID: | PMC10389111 |
| PUBMED: | 37529400 |
| Notes: | The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Corresponding author is MSK author: Ian Ganly -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work